Correction

Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei Yu Chen, Lei Fang, Paul Hynes, Yao Yu Hsieh, Yen Nien Liu, Jiaoti Huang, Kathleen Kelly

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original languageEnglish
Pages (from-to)32403
Number of pages1
JournalOncotarget
Volume9
Issue number64
DOIs
Publication statusPublished - Aug 17 2018

Fingerprint

Bone Neoplasms
Protein-Tyrosine Kinases
Prostatic Neoplasms
Medicine
Neoplasm Metastasis
Hematology
Internal Medicine
Taiwan

ASJC Scopus subject areas

  • Oncology

Cite this

Correction : Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. / Siu, Man Kit; Abou-Kheir, Wassim; Yin, Juan Juan; Chang, Yung Sheng; Barrett, Ben; Suau, Florent; Casey, Orla; Chen, Wei Yu; Fang, Lei; Hynes, Paul; Hsieh, Yao Yu; Liu, Yen Nien; Huang, Jiaoti; Kelly, Kathleen.

In: Oncotarget, Vol. 9, No. 64, 17.08.2018, p. 32403.

Research output: Contribution to journalComment/debate

Siu, Man Kit ; Abou-Kheir, Wassim ; Yin, Juan Juan ; Chang, Yung Sheng ; Barrett, Ben ; Suau, Florent ; Casey, Orla ; Chen, Wei Yu ; Fang, Lei ; Hynes, Paul ; Hsieh, Yao Yu ; Liu, Yen Nien ; Huang, Jiaoti ; Kelly, Kathleen. / Correction : Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. In: Oncotarget. 2018 ; Vol. 9, No. 64. pp. 32403.
@article{79bfee96310947239f191b500b85ea0b,
title = "Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994",
abstract = "This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.",
author = "Siu, {Man Kit} and Wassim Abou-Kheir and Yin, {Juan Juan} and Chang, {Yung Sheng} and Ben Barrett and Florent Suau and Orla Casey and Chen, {Wei Yu} and Lei Fang and Paul Hynes and Hsieh, {Yao Yu} and Liu, {Yen Nien} and Jiaoti Huang and Kathleen Kelly",
year = "2018",
month = "8",
day = "17",
doi = "10.18632/oncotarget.26020",
language = "English",
volume = "9",
pages = "32403",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "64",

}

TY - JOUR

T1 - Correction

T2 - Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

AU - Siu, Man Kit

AU - Abou-Kheir, Wassim

AU - Yin, Juan Juan

AU - Chang, Yung Sheng

AU - Barrett, Ben

AU - Suau, Florent

AU - Casey, Orla

AU - Chen, Wei Yu

AU - Fang, Lei

AU - Hynes, Paul

AU - Hsieh, Yao Yu

AU - Liu, Yen Nien

AU - Huang, Jiaoti

AU - Kelly, Kathleen

PY - 2018/8/17

Y1 - 2018/8/17

N2 - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

AB - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=85051835232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051835232&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26020

DO - 10.18632/oncotarget.26020

M3 - Comment/debate

VL - 9

SP - 32403

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 64

ER -